Abstract:SCN5A gene encoding human cardiac voltage-gated sodium channel α unit is responsible for Brugada syndrome, a disease characterized by ST segment elevation in ECG precordial lead of V_1-V_3 with or without right bundle-branch block, and in cases in which sudden death or syncope occurs, polymorphic ventricular tachycardia (VT) or ventricular fibrillation (VF) may be present. Up to date, more than 10 different mutations, all located in SCN5A gene, have been identified. To understand the association of SCN5A gene mutation with this potentially fatal disease in chinese population, we performed genetic screening in 4 Chinese Brugada syndrome families by way of polymerase chain reaction-single strand conformation polymorphism, and identified an aberrant band in the exon 8 of SCN5A gene in one of the 4 familes which was not present in a cohort of ore than 200 unrelated normal individuals. Direct sequence analysis revealed a G→C transition in the third nucleotide of codon 317 resulting in a substitution of lysine by asparagine (K317N) in extracellular linker between S5 and S6 segments in Domain I of the sodium channel protein. In spite of failure in performing biological expression observations of this mutation, we believe that K317N may affect the permeability of the cardiac sodium channel leading to a decrease of Na+ in-flow during the spike potential of action potential and thus leaving Ito (transient outward current) unopposed at the end of phase I. Family investigation found 10 carriers of this mutation in the total of 21 members in this family, and only 3 carriers had typical ECG pattern at rest, and 4 members who experienced syncope or sudden death all carried this mutation. Our study reveals for the first time that Chinese Brugada syndrome family is associated with SCN5A mutation that is passed down through autosomal dominant heredity, and that the phenotype is not always consistent with the genotype and the penetrance of this mutation is rather low. The findings of this study may provide better insight into the molecular mechanisms of this disease and may potentially facilitate the genetic diagnosis ad therapy of Brugada syndrome in Chinese.

Research Progression on Genetic Mutations Associated with Brugada Syndrome

The Frameshift Mutation of Gene SCN5A Leads to Brugada Syndrome

Cellular Modeling and Simulation of Brugada Syndrome

The research progress on genetic mutations Associated with subtype of Brugada syndrome

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Genetic and Molecular Mechanisms in Brugada Syndrome

Patient-specific Ipsc-Derived Cardiomyocytes Reveal Aberrant Activation of Wnt/β-catenin Signaling in SCN5A-related Brugada Syndrome

[Novel SCN5A Gene Mutations Associated with Brugada Syndrome: V95I, A1649V and Delf1617].

Single Nucleotide Polymorphisms of the S CN5A Gene in Han Chinese and Their Relation with Brugada Syndrome

Molecular genetics of Brugada syndrome

Present Status of Brugada Syndrome: JACC State-of-the-Art Review

Functional Analysis of a Novel SCN5A Mutation G1712C Identified in Brugada Syndrome

Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Gain‐of‐Function KCNH2 Mutations in Patients with Brugada Syndrome

A novel gene mutation of K317N in a Chinese Brugada syndrome family

Electrophysiological Characteristics Of A Scn5a Voltage Sensors Mutation R1629q Associated With Brugada Syndrome

Genetic Characteristics and Transcriptional Regulation of Sodium Channel Related Genes in Chinese Patients with Brugada Syndrome

Cellular and Ionic Mechanisms Responsible for the Brugada Syndrome.

Genetic Analysis of Brugada Syndrome and Congenital Long-Qt Syndrome Type 3 in the Chinese

Genetic Analysis of Brugada Syndrome in Chinese: a Novel SCN5A Gene Mutation

Brugada Syndrome: A Comprehensive Review of Pathophysiological Mechanisms and Risk Stratification Strategies.